Superbug Linked to Death of Babies in Britain

Superbug, which is resistant to common antibiotics, has taken life of three babies at one of Britain's leading hospitals.

The babies in the hospital's neo-natal unit were infected with gram-negative bacteria, an official confirmed.

WHO Urges Health Experts to Monitor New Superbug
The World Health Organisation on Friday called on health authorities around the globe to monitor a multi-drug resistant superbug that surfaced in South Asia and spread to Britain.

One died with the infection at University College Hospital, London, two of other causes and a fourth baby recovered.

The babies were among 15 at the unit over six weeks found to be carrying several types of bacteria. Thirteen of them had bacteria resistant to treatment with gentamicin, an antibiotic used to treat premature babies.

Of those, nine were carrying the bacteria on their skin and four had it in their blood streams. A meeting was held at the hospital on August 10th.

'Indian' Superbug may Not be All That Bad Afterall
An expert has revealed that the NDM-1 bacteria, resistant to almost all antibiotics, has been around for three years and may not be as bad as it is thought to be.

"Development of antibiotic resistance is unfortunately a common occurrence for all neonatal units, even more so in units such as ours which care for the most premature babies," the Daily Express quoted University College London Hospitals NHS Foundation Trust as saying.

"During July we became concerned because we found particular bacteria on routine surveillance.

Belgian Man Becomes the First Superbug Victim
A Belgian man became the first known fatality of a drug-resistant superbug originating in South Asia, reinforcing fears the germ could spread worldwide after infecting dozens of

"We increased cleaning and changed our routine antibiotics to those which we knew would kill these organisms," Trust added.

Source-ANI

Superbug Does Not Affect Medical Tourism Numbers
The number of patients who flock to India to get treatment continues to rise even after a report published in a leading British medical journal warned about superbugs